In vivo effects of balanced, low molecular 6% and 10% hydroxyethyl starch compared with crystalloid volume replacement on the coagulation system in major pancreatic surgery—a sub-analysis of a prospective double-blinded, randomized controlled trial
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0303165 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, 2024. Verfasst von Alexander Eckers und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universi…. Hauptthemen laut MEDLINE: Hydroxyethyl Starch Derivatives, Crystalloid Solutions, Blood Coagulation. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: B. Braun Melsungen.
Abstract (Originalsprache)
Background
The outcome of patients undergoing major surgery treated with HES for hemodynamic optimization is unclear. This post-hoc analysis of a randomized clinical pilot trial investigated the impact of low-molecular balanced HES solutions on the coagulation system, blood loss and transfusion requirements.
Methods
The Trial was registered: EudraCT 2008-004175-22 and ethical approval was provided by the ethics committee of Berlin. Patients were randomized into three groups receiving either a 10% HES 130/0.42 solution, a 6% HES 130/0.42 solution or a crystalloid following a goal-directed hemodynamic algorithm. Endpoints were parameters of standard and viscoelastic coagulation laboratory, blood loss and transfusion requirements at baseline, at the end of surgery (EOS) and the first postoperative day (POD 1).
Results
Fifty-two patients were included in the analysis (HES 10% (n = 15), HES 6% (n = 17) and crystalloid (n = 20)). Fibrinogen decreased in all groups at EOS (HES 10% 338 [298;378] to 192 [163;234] mg dl -1 , p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Hea…
- Institute of Medical Informatics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
- Institute of Biometry and Clinical Epidemiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
- Department of Anesthesia, Intensive Care Medicine, Emergency Medicine and Pain Therapy, Vivantes Klinikum im Friedrichshain, Berlin, Germany.
ORCID-Profile: Alexander Eckers, Claudia Spies, Felix Balzer, Kerstin Rubarth, Christian von Heymann
Förderung
- B. Braun Melsungen
Zitieren
APA
Eckers, A., Hunsicker, O., Spies, C., Balzer, F., Rubarth, K., & von Heymann, C. (2024). In vivo effects of balanced, low molecular 6% and 10% hydroxyethyl starch compared with crystalloid volume replacement on the coagulation system in major pancreatic surgery—a sub-analysis of a prospective double-blinded, randomized controlled trial. PLOS ONE. https://doi.org/10.1371/journal.pone.0303165
Vancouver
Eckers A, Hunsicker O, Spies C, Balzer F, Rubarth K, von Heymann C. In vivo effects of balanced, low molecular 6% and 10% hydroxyethyl starch compared with crystalloid volume replacement on the coagulation system in major pancreatic surgery—a sub-analysis of a prospective double-blinded, randomized controlled trial. PLOS ONE. 2024. doi:10.1371/journal.pone.0303165
BibTeX
@article{Eckers2024,
author = {Eckers, Alexander and Hunsicker, Oliver and Spies, Claudia and Balzer, Felix and Rubarth, Kerstin and von Heymann, Christian},
title = {In vivo effects of balanced, low molecular 6% and 10% hydroxyethyl starch compared with crystalloid volume replacement on the coagulation system in major pancreatic surgery—a sub-analysis of a prospective double-blinded, randomized controlled trial},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0303165}
}
EUVIMED